The Prognostic Value of Circulating VEGF-A Level in Patients With Hepatocellular Cancer.

Published in: Technology in cancer research & treatment (2021)

Serum VEGF-A level, a biological marker of angiogenesis, is an independent predictor of survival in patients with HCC. Serum VEGF-A levels may be utilized to predict response to treatment targeting serum VEGF-A in patients with HCC.

Keyphrases

vascular endothelial growth factor
endothelial cells
papillary thyroid
cancer therapy
squamous cell
young adults
free survival
drug delivery
wound healing